BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37919077)

  • 1. C3aR Antagonist Alleviates C3a Induced Tubular Profibrotic Phenotype Transition via Restoring PPARα/CPT-1α Mediated Mitochondrial Fatty Acid Oxidation in Renin-Dependent Hypertension.
    Wang C; Wang Z; Xu J; Ma H; Jin K; Xu T; Pan X; Feng X; Zhang W
    Front Biosci (Landmark Ed); 2023 Oct; 28(10):238. PubMed ID: 37919077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C3a/C3aR synergies with TGF-β to promote epithelial-mesenchymal transition of renal tubular epithelial cells via the activation of the NLRP3 inflammasome.
    You D; Nie K; Wu X; Weng M; Yang L; Chen Y; Cui J; Wan J
    J Transl Med; 2023 Dec; 21(1):904. PubMed ID: 38082306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophages promote heat stress nephropathy in mice via the C3a-C3aR-TNF pathway.
    Yang Y; Zhang D; Song M; Wang C; Lv J; Zhou J; Chen M; Ma L; Mei C
    Immunobiology; 2023 Mar; 228(2):152337. PubMed ID: 36689826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The "C3aR Antagonist" SB290157 is a Partial C5aR2 Agonist.
    Li XX; Kumar V; Clark RJ; Lee JD; Woodruff TM
    Front Pharmacol; 2020; 11():591398. PubMed ID: 33551801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of PPAR
    Chung KW; Lee EK; Lee MK; Oh GT; Yu BP; Chung HY
    J Am Soc Nephrol; 2018 Apr; 29(4):1223-1237. PubMed ID: 29440279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator activated receptor alpha (PPARalpha) and PPAR gamma coactivator (PGC-1alpha) induce carnitine palmitoyltransferase IA (CPT-1A) via independent gene elements.
    Song S; Attia RR; Connaughton S; Niesen MI; Ness GC; Elam MB; Hori RT; Cook GA; Park EA
    Mol Cell Endocrinol; 2010 Aug; 325(1-2):54-63. PubMed ID: 20638986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shiga Toxin 2 Triggers C3a-Dependent Glomerular and Tubular Injury through Mitochondrial Dysfunction in Hemolytic Uremic Syndrome.
    Buelli S; Locatelli M; Carminati CE; Corna D; Cerullo D; Imberti B; Perico L; Brigotti M; Abbate M; Zoja C; Benigni A; Remuzzi G; Morigi M
    Cells; 2022 May; 11(11):. PubMed ID: 35681450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shen-Shuai-II-Recipe inhibits tubular inflammation by PPARα-mediated fatty acid oxidation to attenuate fibroblast activation in fibrotic kidneys.
    Wang M; Wang L; Zhou L; Xu Y; Wang C
    Phytomedicine; 2024 Apr; 126():155450. PubMed ID: 38368794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aristolocholic acid I promotes renal tubular epithelial fibrosis by upregulating matrix metalloproteinase-9 expression via activating the C3a/C3aR axis of macrophages.
    Zhang Q; Ye J; Zhang Z; Hu Y; Wang X; Jiang W; Guo X; Chen L; Cheng S; Li J; Zhang L
    Toxicol Lett; 2023 May; 381():27-35. PubMed ID: 37084829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of anaphylatoxin C3a, C5a on the tubular epithelial-myofibroblast transdifferentiation in vitro.
    Liu F; Gou R; Huang J; Fu P; Chen F; Fan WX; Huang YQ; Zang L; Wu M; Qiu HY; Wei DP
    Chin Med J (Engl); 2011 Dec; 124(23):4039-45. PubMed ID: 22340339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of KLF14 expression attenuates kidney fibrosis by inducing PPARα-mediated fatty acid oxidation.
    Chen L; Sha ML; Chen FT; Jiang CY; Li D; Xu CL; Pan DS; Xu ZJ; Tang QL; Xia SJ; Sun LH; Fan GJ; Shao Y
    Free Radic Biol Med; 2023 Feb; 195():132-144. PubMed ID: 36584797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement C3a and C3a Receptor Activation Mediates Podocyte Injuries in the Mechanism of Primary Membranous Nephropathy.
    Gao S; Cui Z; Zhao MH
    J Am Soc Nephrol; 2022 Sep; 33(9):1742-1756. PubMed ID: 35777783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy.
    Tang Z; Lu B; Hatch E; Sacks SH; Sheerin NS
    J Am Soc Nephrol; 2009 Mar; 20(3):593-603. PubMed ID: 19158354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twist1 downregulation of PGC-1α decreases fatty acid oxidation in tubular epithelial cells, leading to kidney fibrosis.
    Liu L; Ning X; Wei L; Zhou Y; Zhao L; Ma F; Bai M; Yang X; Wang D; Sun S
    Theranostics; 2022; 12(8):3758-3775. PubMed ID: 35664054
    [No Abstract]   [Full Text] [Related]  

  • 15. Berberine Protects Against Palmitate-Induced Apoptosis in Tubular Epithelial Cells by Promoting Fatty Acid Oxidation.
    Sun J; Chen X; Liu T; Jiang X; Wu Y; Yang S; Hua W; Li Z; Huang H; Ruan X; Du X
    Med Sci Monit; 2018 Mar; 24():1484-1492. PubMed ID: 29528039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aristolochic acid I aggravates renal injury by activating the C3a/C3aR complement system.
    Ye J; Qian Z; Xue M; Liu Y; Zhu S; Li Y; Liu X; Cai D; Rui J; Zhang L
    Toxicol Lett; 2019 Sep; 312():118-124. PubMed ID: 31048001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and role of soluble epoxide hydrolase in renal tissue of two kidneys one clip hypertension rats model].
    Pan YJ; Tao ZF; Wang Q; Lu M; Guan YF; Zhu Y; Wang Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 43(6):820-6. PubMed ID: 22178827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yishen Jiangzhuo Granules affect tubulointerstitial fibrosis via a mitochondrion-mediated apoptotic pathway.
    Xu YF; Ruan SW; Lin JM; Zhang Z
    Chin J Integr Med; 2015 Dec; 21(12):928-37. PubMed ID: 25956968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
    Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
    Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT6 promoting oxalate crystal deposition-induced renal fibrosis by mediating macrophage-to-myofibroblast transition via inhibiting fatty acid oxidation.
    Yuan T; Xia Y; Pan S; Li B; Ye Z; Yan X; Hu W; Li L; Song B; Yu W; Li H; Rao T; Lin F; Zhou X; Cheng F
    Inflamm Res; 2023 Dec; 72(12):2111-2126. PubMed ID: 37924395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.